Summary : AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic…
Tag:
Leading
-
-
Agrochemicals
Cipla launches ‘Spirofy’, Pneumotach-Based Portable Wireless Spirometer for Early Diagnosis of COPD
by adminby adminKEYPOINTS: Spirofy is India’s first pneumotach-based portable wireless Spirometer for the diagnosis of COPD and asthma. The company intends with this launch…
-
AstraZenecaDapagliflozin
NICE issues Draft Recommendation for AstraZeneca`s Forxiga (Dapagliflozin) to Treat Adults with Chronic Kidney Disease
by adminby adminAbstract: The National Institute for Health and Care Excellence (NICE) has issued an Appraisal Consultation Document (ACD) for AstraZeneca’s Forxiga (Dapagliflozin) within…
-
UPL Ltd
UPL Ltd. Launches New ‘NPP’ Business Unit to Enhance Biosolutions Capacity for Sustainable Agriculture in Europe.
by adminby adminKeypoints UPL is the largest manufacturer and distributor of biosolutions worldwide. On 28 June 2021 UPL Ltd, a world leader in sustainable…
-
Agro Science & Research
UPL and Chr. Hansen announce a long-term Collaboration to develop and Commercialize Microbial Solutions for Sustainable Agriculture.
by adminby adminKeypoints Hansen is joining forces with global agricultural solutions provider UPL in a unique partnership to strengthen the existing portfolio of microbial…